ALO-212

N/A

Report date: 2023/01/12 15:51:45

Base Information

Drug NameALO-212
Drug Alias NameALO-212
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsPeripheral Vascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesIsto Biologics
China Registration ClassN/A

Develop Information

Active CompaniesIsto Biologics
Inactive CompaniesN/A
Active IndicationsPeripheral Vascular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A